Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|September 3, 2025
Physical activity in older cancer patients: evidence and clinical implicationsShugo Yajima, Shin Kobayashi, Tadayoshi Hashimoto, et al.
Journal of Gastric Cancer|October 3, 2018
Surgical Treatment of Gastroesophageal Junction CancerTadayoshi Hashimoto, Yukinori Kurokawa, Masaki Mori, et al.
JMA Journal|March 22, 2021
Update on the Treatment of Gastric CancerTadayoshi Hashimoto, Yukinori Kurokawa, Masaki Mori, et al.
Urologic Oncology|May 25, 2026
Diagnostic performance of urinary tumor DNA in urothelial carcinoma: A systematic review and network meta-analysisShugo Yajima, Naoki Imasato, Tadayoshi Hashimoto, et al.
International Journal of Clinical Oncology|March 29, 2024
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assayTadayoshi Hashimoto, Yoshiaki Nakamura, Eiji Oki, et al.
BMJ Open|August 16, 2023
Utility of circulating tumour DNA for prognosis and prediction of therapeutic effect in locally recurrent rectal cancer: study protocol for a multi-institutional, prospective observational study (JCOG1801A1, CAP-LR study)Tadayoshi Hashimoto, Yuichiro Tsukada, Masaaki Ito, et al.
Future Oncology (London, England)|September 26, 2023
A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, et al.
Future Oncology (London, England)|August 16, 2023
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancerTadayoshi Hashimoto, Satoshi Otsu, Shuichi Hironaka, et al.
Japanese Journal of Clinical Oncology|March 27, 2021
A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study)Ryo Shimoyama, Kazuo Nakagawa, Satoshi Ishikura, et al.
Oncology Letters|January 4, 2020
Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancerTadayoshi Hashimoto, Yukinori Kurokawa, Noriko Wada, et al.
Pageof 8